RxDoctor Payments Data

Roman Mirsky, MD

Nuclear Imaging & Therapy · Des Moines, IANPI 1114915527

Payments from drug & device makers

$464in general payments, 2019–2025

Across 7 payments — averaging $66.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$141
  • Pfizer$125
  • Progenics Pharmaceuticals, Inc.$107
  • United Imaging Healthcare North America LLC$55
  • Hologic Sales And Service, LLC$19
  • Lilly USA, LLC$17

What the payments were for

  • Food & beverage$464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca2$141
Pfizer1$125
Progenics Pharmaceuticals, Inc.1$107
United Imaging Healthcare North America LLC1$55
Hologic Sales And Service, LLC1$19
Lilly USA, LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few nuclear imaging & therapy providers in Iowato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$238,230
Medicare patients
3,880
Services billed
6,153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Where these figures come from

Is this you, or does something look wrong? →